Muutke küpsiste eelistusi

E-raamat: Unlocking Cancer's Hidden Targets

  • Formaat: EPUB+DRM
  • Ilmumisaeg: 13-Apr-2026
  • Kirjastus: Distributed via Draft2Digital
  • Keel: eng
  • ISBN-13: 9798995580805
Teised raamatud teemal:
  • Formaat - EPUB+DRM
  • Hind: 17,49 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Lisa ostukorvi
  • Lisa soovinimekirja
  • See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.
Unlocking Cancer's Hidden Targets
  • Formaat: EPUB+DRM
  • Ilmumisaeg: 13-Apr-2026
  • Kirjastus: Distributed via Draft2Digital
  • Keel: eng
  • ISBN-13: 9798995580805
Teised raamatud teemal:

DRM piirangud

  • Kopeerimine (copy/paste):

    ei ole lubatud

  • Printimine:

    ei ole lubatud

  • Kasutamine:

    Digitaalõiguste kaitse (DRM)
    Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale  Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

    Vajalik tarkvara
    Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

    PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

    Seda e-raamatut ei saa lugeda Amazon Kindle's. 

Unlocking Cancer's Hidden Targets: The Revolutionary Science of Cancer-Testis Antigens in Modern Immunotherapy is a comprehensive scientific guide that explores the groundbreaking intersection of cancer-testis antigen research and modern immunotherapy. Written by Dr. Maurizio Chiriva Internati, a pioneering researcher with over two decades of experience in immuno-oncology, this book provides an in-depth examination of how cancer-testis antigens are transforming the landscape of personalized cancer treatment.From the foundational discovery of sperm protein 17 as a novel cancer-testis antigen to the development of AI-driven platforms for personalized target discovery, this work covers the full spectrum of translational research in cancer immunotherapy. Readers will explore the molecular mechanisms underlying cancer-testis antigen expression, the clinical applications of cancer vaccines across multiple tumor types, and the revolutionary manufacturing processes that are making personalized immunotherapy a clinical reality.This book bridges the gap between laboratory science and clinical application, offering oncologists, immunologists, biotech professionals, medical students, and researchers a thorough understanding of the current state and future directions of cancer-testis antigen-based immunotherapy. With over 215 scientific references and detailed analysis of FDA regulatory pathways, vaccine development strategies, and emerging technologies including mRNA-based cancer vaccines, this work serves as both an authoritative reference and an accessible guide to one of the most promising frontiers in modern oncology.
Ei ole sisse logitud.